Find out all about your favorite commercial!

Advertisers

Advertisers of the Tecfidera TV Spot, 'Relapsing Multiple Sclerosis'

Tecfidera TV commercial - Relapsing Multiple Sclerosis
Tecfidera

About TecfideraTecfidera is a prescription medication used to treat people with relapsing forms of multiple sclerosis (MS), a chronic disease of the central nervous system. It is manufactured by Bioge...

What the Tecfidera TV commercial - Relapsing Multiple Sclerosis is about.

Tecfidera TV commercial - Relapsing Multiple Sclerosis

Title: Tecfidera TV Spot: Empowering Lives Affected by Relapsing Multiple Sclerosis

Introduction:The Tecfidera TV Spot is a powerful depiction of hope, strength, and resilience in the face of relapsing multiple sclerosis (MS). Expertly crafted to raise awareness about this chronic illness, the commercial captures the journey of those living with MS while highlighting the potential benefits of Tecfidera as a treatment option. With a blend of emotional storytelling and informative messaging, the TV spot aims to empower individuals with the information they need to take control of their MS management.

Synopsis:The TV spot begins with a visually captivating scene that showcases the vibrant life of the protagonist, who is revealed to be living with relapsing MS. Bright sunlight streams through the windows, illuminating the character's daily routine as they go about their life. From enjoying a walk in the park to engaging in family moments, the protagonist embodies the spirit of determination and resilience.

As the scene transitions, the tone becomes more profound, reflecting the challenges and uncertainties that relapsing MS can bring. The protagonist's voiceover narrates their personal journey with the disease, emphasizing the need for effective treatment options. The TV spot then introduces Tecfidera as a potential solution, presenting it as a tried and tested treatment option for relapsing MS.

The commercial showcases the transformative effects of Tecfidera, with a gradual shift in the protagonist's life as they regain control over their disease. Scenes of the protagonist engaging in their favorite activities with renewed energy are interspersed with graphics displaying key facts about Tecfidera's efficacy in reducing relapses and slowing down the progression of MS. These visuals effectively convey the message that life after an MS diagnosis can be vibrant and fulfilling with the help of the right treatment.

Towards the end of the TV spot, healthcare professionals or individuals within the MS community appear on screen, speaking about their positive experiences with Tecfidera. Their testimonials instill a sense of trust and reassurance, further strengthening the credibility of Tecfidera as a viable treatment option for relapsing MS.

The TV spot concludes with the protagonist confidently stating that MS does not define their life, emphasizing the importance of taking control of the disease. The screen then displays a call-to-action, urging viewers to consult their healthcare provider to learn more about Tecfidera and discuss whether it is the right choice for them.

Takeaway:The Tecfidera TV Spot masterfully combines storytelling, educational information, and real-life testimonials to create an emotionally compelling narrative. It not only raises awareness about the challenges faced by individuals living with relapsing MS but also offers hope and emphasizes the potential benefits of Tecfidera as a promising treatment option. By providing a sense of empowerment and encouraging proactive medical conversations, the TV spot plays a crucial role in supporting those affected by relapsing MS on their journey to reclaiming their lives.

Tecfidera TV commercial - Relapsing Multiple Sclerosis produced for Tecfidera was first shown on television on October 4, 2015.

Frequently Asked Questions about tecfidera tv spot, 'relapsing multiple sclerosis'

Dimethyl fumarate, known by the brand name Tecfidera, is a disease modifying therapy (DMT) recommended for the treatment of 'active' relapsing multiple sclerosis. This is defined in guidelines as two or more relapses in the last two years.

Data showed that Tecfidera treatment effectively prevented relapses in participants. For those given Tecfidera in the initial trials, the annual relapse rate (ARR) ranged from 0.20 relapses/year in the first year to 0.09 relapses/year by eight to nine years of follow-up.

Official answer. Tecfidera can be taken for as long as it continues to have a clinical benefit and you are not experiencing intolerable or severe side effects.

Tecfidera starts to work within 24 weeks; however, it may take up to two years for the full effects to be seen. Studies report that after 2 years, people taking Tecfidera were: 44% to 53% less likely to relapse every year when taking Tecfidera compared with those taking placebo.

be vigilant for any new or worsening neurological or psychiatric symptoms and seek urgent medical attention if they occur – these may include altered vision, weakness, confusion, speech problems, or personality changes lasting for more than a few days.

Flushing/warmth, redness, itching, and burning feeling of the skin may occur. Taking this drug with food may reduce flushing. Stomach/abdominal pain, diarrhea, nausea, and vomiting may also occur. These effects usually improve or go away as your body adjusts to the medication.

According to the findings, around 51% of participants did not relapse with Tecfidera treatment over the study duration. Furthermore, 64% did not experience confirmed disability progression, while 79% retained the capacity to walk with no significant disability.

Ocrevus and Tysabri account for over 85% of the patient share of multiple sclerosis medications. Ocrevus experienced a 5.6% year-over-year (YoY) growth, while all other top 10 medications experienced less than a 1.8% YoY change in variance.

No, stopping Tecfidera treatment shouldn't cause side effects. However, stopping this medication may lead to worsened symptoms or progression of MS.

Answer: Abruptly discontinuing Tecfidera is not an issue for concerns around rebound disease activity (which is a problem with Tysabri and Gilenya, for example). Although you eliminate Tecfidera rapidly by exhaling, there can be more lasting effects of the medication on white blood cell counts.

Studies report that after 2 years, compared to a placebo (an inactive pill), people taking Tecfidera were 44% to 53% less likely to relapse every year, 21% to 28% less likely to have a progression of their disability, and 74% to 90% less likely to develop new or newly enlarging T2 lesions or have Gd lesions.

Tecfidera attained the lowest RxScore of 33 and the lowest ROR of life-threatening events, hospitalizations, disability, or death. It also scored lowest for everything from bacterial infections to optic nerve disorders and liver problems.

Videos

Watch Tecfidera TV Commercial, 'Relapsing Multiple Sclerosis'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Actors

Actors who starred in Tecfidera TV Spot, 'Relapsing Multiple Sclerosis'

Tiffany May photo
Products

Products Advertised

Tecfidera
TV commercials

Similar commercials

XFINITY Home TV Spot, 'Forgetting Something: No Offer'
XFINITY Home TV Spot, 'Peace of Mind'
XFINITY Doorbell TV Spot, 'Jurassic World Dominion: The Herd Comes Home'
U.S. Open TV Spot, '2019: Champions and Contenders'
XFINITY Home TV Spot, 'Welcome to the Neighborhood' Song by Dinah Washington
Troon TV Spot, 'The Diverse World of Troon'
Progressive TV Spot, 'Guys Night Out'
XFINITY Home TV Spot, 'Precious Parcels'
CMT On Tour TV Spot, 'Cole Swindell: Down Home Tour Tickets'
CMT On Tour TV Spot, 'Cole Swindell's Down Home Tour'
Dierks Bentley TV Spot, 'What the Hell Tour'
XFINITY Home TV Spot, 'DIY Projects'